4
Changes in Ownership
Avalyn Pharma Inc. Filed Acc 0001193125-26-201894
Director bought 277,778 shares at $18.00 ($5,000,004)
- Director acquired 1,908,784 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Carroll Jill Director | 2026-05-01 | Conversion | +1,419,298 | 1,419,298 | I | ||
| Carroll Jill Director | 2026-05-01 | Conversion | +489,486 | 1,908,784 | I | ||
| Carroll Jill Director | 2026-05-01 | Purchase | +277,778 | $18.00 | $5,000,004 | 2,186,562 | I |
| Derivatives | |||||||
| Carroll Jill Director | 2026-05-01 | Conversion · Series C-1 Convertible Preferred Stock | −27,309,719 | 0 | I | ||
| Carroll Jill Director | 2026-05-01 | Conversion · Series D Convertible Preferred Stock | −9,418,561 | 0 | I | ||
| Open-market purchases · 277,778 sh · avg $18.00 · $5,000,004 | |||||||
Loading xslF345X06/ownership.xml…